Understanding the structural requirements for covalent inhibition of FGFR1-3
Yosaatmadja, Y., Squire, C.J., Patterson, A.V., Smaill, J.B.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Fibroblast growth factor receptor 1 | 311 | Homo sapiens | Mutation(s): 2  Gene Names: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR EC: 2.7.10.1 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P11362 (Homo sapiens) Explore P11362  Go to UniProtKB:  P11362 | |||||
PHAROS:  P11362 GTEx:  ENSG00000077782  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P11362 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
YY4 (Subject of Investigation/LOI) Query on YY4 | C [auth A], D [auth B] | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-{(3S)-1-[(2E)-4-(dimethylamino)but-2-enoyl]pyrrolidin-3-yl}-7-(phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one C30 H33 Cl2 N7 O4 PBXZRBBBLQGCRI-MAIVGLDJSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 213.514 | α = 90 |
b = 52.193 | β = 107.03 |
c = 65.795 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
XDS | data reduction |
Aimless | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
Health Research Council (HRC) | New Zealand | -- |